Inactive Instrument

Apex Healthcare Berhad Stock BURSA MALAYSIA

Equities

Pharmaceuticals

End-of-day quote BURSA MALAYSIA
- MYR - Intraday chart for Apex Healthcare Berhad
Sales 2024 * 999M 212M Sales 2025 * 1.06B 226M Capitalization 2.04B 434M
Net income 2024 * 93M 19.77M Net income 2025 * 104M 22.11M EV / Sales 2024 * 1.84 x
Net cash position 2024 * 204M 43.26M Net cash position 2025 * 216M 45.87M EV / Sales 2025 * 1.72 x
P/E ratio 2024 *
21.9 x
P/E ratio 2025 *
19.7 x
Employees -
Yield 2024 *
1.97%
Yield 2025 *
2.39%
Free-Float 48.93%
More Fundamentals * Assessed data
Apex Healthcare Berhad Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apex Healthcare Berhad Approves Special Dividend for the Financial Year Ended December 31, 2023 CI
Apex Healthcare Berhad Approves Final Single-Tier Dividend for the Financial Year Ended December 31, 2023 CI
Apex Healthcare Berhad Proposes the Special Dividend for the Financial Year Ended 31 December 2023 CI
Apex Healthcare Boosts Dividend Despite Profit Decline in Q4 MT
Apex Healthcare Berhad Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Apex Healthcare Berhad Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI
Apex Healthcare Berhad Proposes Final Single-Tier Dividend for the Financial Year Ended December 31, 2023, Payment Date 29 May 2024 CI
Apex Healthcare Berhad Announces A Special Dividend of the Financial Year Ended 31 December 2023 CI
Apex Healthcare Berhad Announces Promotion of Miss Chiew Woon Wui from Financial Controller to Chief Financial Officer, Effective on January 1, 2024 CI
Apex Healthcare Berhad Announces Promotion of Miss Chiew Woon Wui from Financial Controller to Chief Financial Officer, Effective on January 1, 2024 CI
Apex Healthcare Profit Declines in Q3 MT
Apex Healthcare Berhad Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Apex Healthcare's Profit Shoots Up in Q2 MT
Apex Healthcare Berhad Provides Earnings Guidance for the Year 2023 CI
More news
Managers TitleAgeSince
Chief Executive Officer 62 00-02-14
Director of Finance/CFO 50 01-12-31
Investor Relations Contact - -
Members of the board TitleAgeSince
Director/Board Member 73 00-02-22
Director/Board Member 72 00-02-17
Chief Executive Officer 62 00-02-14
More insiders
Apex Healthcare Berhad is a Malaysia-based healthcare company. The Company is focused on the development, manufacturing, wholesaling, marketing and distribution of pharmaceuticals, consumer healthcare products, and medical devices. It operates through three segments: Manufacturing, Distribution and Corporate. It is engaged in the manufacturing of pharmaceutical products. It is involved in the distribution of pharmaceutical and healthcare products. The Corporate segment comprises investments, properties and others. It is also engaged in the contract manufacturing of orthopedic devices. Its brands include XEPATM, AVO, AGNESIA, AEVA and HENNSON, and products bearing these brands are sold in approximately 16 territories worldwide. The Company's distribution channels reach hospitals, clinics, independent and chain pharmacies, supermarkets and health stores, enabling products to reach customers, namely doctors, pharmacists, nutritionists, retailers, and ultimately the patients or consumers.
More about the company